Reuters logo
BRIEF-U.S. FDA approves Juluca, a two-drug regimen for certain patients with HIV
November 21, 2017 / 7:08 PM / in 21 days

BRIEF-U.S. FDA approves Juluca, a two-drug regimen for certain patients with HIV

Nov 21 (Reuters) - U.S. Food and Drug Administration:

* Approved Juluca, a fixed-dose tablet containing dolutegravir and rilpivirine, to treat adults with HIV-1 infections ‍​

* Granted approval of Juluca to ViiV Healthcare​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below